AIM logo

AIM ImmunoTech (AIM) Current Liabilities

Annual Current Liabilities

$8.65 M
+$7.29 M+535.71%

31 December 2023

AIM Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$10.10 M
+$1.26 M+14.23%

30 September 2024

AIM Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AIM Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+535.7%+114.2%
3 y3 years+685.1%+1216.8%
5 y5 years+63.5%+141.0%

AIM Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1185.6%at high+1400.7%
5 y5 yearsat high+1185.6%at high+1400.7%
alltimeall time-31.6%+1185.6%-20.1%+1400.7%

AIM ImmunoTech Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$10.10 M(+14.2%)
June 2024
-
$8.84 M(-10.5%)
Mar 2024
-
$9.88 M(+14.1%)
Dec 2023
$8.65 M(+535.7%)
$8.65 M(+83.5%)
Sept 2023
-
$4.72 M(+63.5%)
June 2023
-
$2.88 M(+57.0%)
Mar 2023
-
$1.84 M(+35.0%)
Dec 2022
$1.36 M(+102.2%)
$1.36 M(-53.0%)
Sept 2022
-
$2.90 M(+111.6%)
June 2022
-
$1.37 M(+78.6%)
Mar 2022
-
$766.00 K(+13.8%)
Dec 2021
$673.00 K(-38.9%)
$673.00 K(-12.3%)
Sept 2021
-
$767.00 K(-12.4%)
June 2021
-
$876.00 K(-9.7%)
Mar 2021
-
$970.00 K(-12.0%)
Dec 2020
$1.10 M(-2.2%)
$1.10 M(+38.6%)
Sept 2020
-
$795.00 K(-4.6%)
June 2020
-
$833.00 K(+18.5%)
Mar 2020
-
$703.00 K(-37.6%)
Dec 2019
$1.13 M(-78.7%)
$1.13 M(-73.1%)
Sept 2019
-
$4.19 M(+139.9%)
June 2019
-
$1.75 M(-16.3%)
Mar 2019
-
$2.09 M(-60.6%)
Dec 2018
$5.29 M(+95.5%)
$5.29 M(+6.7%)
Sept 2018
-
$4.96 M(+138.9%)
June 2018
-
$2.08 M(-21.6%)
Mar 2018
-
$2.65 M(-2.1%)
Dec 2017
$2.71 M(+11.2%)
$2.71 M(+23.0%)
Sept 2017
-
$2.20 M(-19.8%)
June 2017
-
$2.74 M(+4.1%)
Mar 2017
-
$2.64 M(+8.3%)
Dec 2016
$2.44 M(+0.1%)
$2.44 M(+0.2%)
Sept 2016
-
$2.43 M(-45.1%)
June 2016
-
$4.43 M(+43.2%)
Mar 2016
-
$3.09 M(+27.1%)
Dec 2015
$2.43 M(-45.2%)
$2.43 M(-26.9%)
Sept 2015
-
$3.33 M(+7.3%)
June 2015
-
$3.10 M(-18.8%)
Mar 2015
-
$3.82 M(-13.9%)
Dec 2014
$4.44 M(+75.2%)
$4.44 M(+4.2%)
Sept 2014
-
$4.26 M(+2.3%)
June 2014
-
$4.16 M(+39.3%)
Mar 2014
-
$2.99 M(+18.0%)
Dec 2013
$2.53 M(-80.0%)
$2.53 M(-76.2%)
Sept 2013
-
$10.63 M(+7.8%)
June 2013
-
$9.86 M(-1.7%)
Mar 2013
-
$10.03 M(-20.7%)
Dec 2012
$12.65 M(+149.5%)
$12.65 M(+29.2%)
Sept 2012
-
$9.79 M(+33.1%)
June 2012
-
$7.36 M(+23.0%)
Mar 2012
-
$5.98 M(+18.0%)
Dec 2011
$5.07 M(+79.0%)
$5.07 M(+40.7%)
Sept 2011
-
$3.60 M(+84.9%)
June 2011
-
$1.95 M(-31.2%)
Mar 2011
-
$2.83 M(0.0%)
Dec 2010
$2.83 M
$2.83 M(+19.9%)
Sept 2010
-
$2.36 M(+25.7%)
June 2010
-
$1.88 M(-23.6%)
DateAnnualQuarterly
Mar 2010
-
$2.46 M(-6.0%)
Dec 2009
$2.62 M(+56.9%)
$2.62 M(+88.8%)
Sept 2009
-
$1.39 M(-45.4%)
June 2009
-
$2.54 M(+3.6%)
Mar 2009
-
$2.45 M(+46.8%)
Dec 2008
$1.67 M(-23.8%)
$1.67 M(-22.9%)
Sept 2008
-
$2.16 M(+11.7%)
June 2008
-
$1.94 M(-12.2%)
Mar 2008
-
$2.21 M(+0.8%)
Dec 2007
$2.19 M(-67.3%)
$2.19 M(-17.9%)
Sept 2007
-
$2.66 M(-6.8%)
June 2007
-
$2.86 M(-58.7%)
Mar 2007
-
$6.91 M(+3.5%)
Dec 2006
$6.68 M(+259.9%)
$6.68 M(-7.4%)
Sept 2006
-
$7.22 M(+6.6%)
June 2006
-
$6.77 M(+187.4%)
Mar 2006
-
$2.36 M(+26.9%)
Dec 2005
$1.86 M(-47.6%)
$1.86 M(-67.6%)
Sept 2005
-
$5.74 M(+1.1%)
June 2005
-
$5.67 M(+10.9%)
Mar 2005
-
$5.12 M(+44.4%)
Dec 2004
$3.54 M(+120.6%)
$3.54 M(-2.6%)
Sept 2004
-
$3.64 M(+28.5%)
June 2004
-
$2.83 M(-39.5%)
Mar 2004
-
$4.68 M(+191.3%)
Dec 2003
$1.61 M(+9.8%)
$1.61 M(-22.1%)
Sept 2003
-
$2.06 M(+21.1%)
June 2003
-
$1.70 M(-39.7%)
Mar 2003
-
$2.83 M(+93.0%)
Dec 2002
$1.46 M(+15.1%)
$1.46 M(+56.7%)
Sept 2002
-
$934.00 K(+14.2%)
June 2002
-
$818.00 K(-39.4%)
Mar 2002
-
$1.35 M(+6.1%)
Dec 2001
$1.27 M(-14.9%)
$1.27 M(+1.8%)
Sept 2001
-
$1.25 M(+11.3%)
June 2001
-
$1.12 M(-9.4%)
Mar 2001
-
$1.24 M(-17.1%)
Dec 2000
$1.50 M(-0.3%)
$1.50 M(+65.5%)
Sept 2000
-
$903.40 K(-27.4%)
June 2000
-
$1.25 M(+5.4%)
Mar 2000
-
$1.18 M(-21.2%)
Dec 1999
$1.50 M(+36.4%)
$1.50 M(-28.6%)
Sept 1999
-
$2.10 M(-4.5%)
June 1999
-
$2.20 M(+29.4%)
Mar 1999
-
$1.70 M(+54.5%)
Dec 1998
$1.10 M(+37.5%)
$1.10 M(+22.2%)
Sept 1998
-
$900.00 K(-10.0%)
June 1998
-
$1.00 M(+25.0%)
Mar 1998
-
$800.00 K(0.0%)
Dec 1997
$800.00 K(-27.3%)
$800.00 K(-42.9%)
Sept 1997
-
$1.40 M(+40.0%)
June 1997
-
$1.00 M(0.0%)
Mar 1997
-
$1.00 M(-9.1%)
Dec 1996
$1.10 M(-86.7%)
$1.10 M(0.0%)
Sept 1996
-
$1.10 M(-21.4%)
June 1996
-
$1.40 M(+7.7%)
Mar 1996
-
$1.30 M(-84.3%)
Dec 1995
$8.30 M
$8.30 M

FAQ

  • What is AIM ImmunoTech annual total current liabilities?
  • What is the all time high annual current liabilities for AIM ImmunoTech?
  • What is AIM ImmunoTech annual current liabilities year-on-year change?
  • What is AIM ImmunoTech quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly current liabilities year-on-year change?

What is AIM ImmunoTech annual total current liabilities?

The current annual current liabilities of AIM is $8.65 M

What is the all time high annual current liabilities for AIM ImmunoTech?

AIM ImmunoTech all-time high annual total current liabilities is $12.65 M

What is AIM ImmunoTech annual current liabilities year-on-year change?

Over the past year, AIM annual total current liabilities has changed by +$7.29 M (+535.71%)

What is AIM ImmunoTech quarterly total current liabilities?

The current quarterly current liabilities of AIM is $10.10 M

What is the all time high quarterly current liabilities for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly total current liabilities is $12.65 M

What is AIM ImmunoTech quarterly current liabilities year-on-year change?

Over the past year, AIM quarterly total current liabilities has changed by +$5.38 M (+114.16%)